SSPY $SPX $GILD  Announcement of remdesivir trial results by NIAID.  1st high powered placebo controlled trial, US and other countries in Europe. Time to recovery was primary endpoint.  Safety monitoring board told Fauci tha... https://t.co/BQXQvsOfZG